Comparison of Biodentine and MTA Pulpotomies in the Primary Molar Teeth 3 Year Follow up

Istanbul University

Status and phase: Completed; Early Phase 1

Conditions: Dental Caries; Pulpotomy

Treatments: Drug: ProRoot (Aggregate); Drug: Biodentine

Study type: Interventional

Funder types: Other

Identifiers

NCT03395496

2017-24692

Details and patient eligibility

About

The aim of this study is to compare two pulpotomy medicaments in primary molars clinically.A total of 200 primary molars with deep caries were treated with two different pulpotomy medicaments (Mineral Trioxide Aggregate and BiodentineTM) in this study. The inclusion criteria for tooth selection were no clinical and radiographic evidence of pulp pathology. During 36 months of follow-up at 3-month intervals, clinical and radiographic success and failures were recorded.

Enrollment: 200 patients

Sex: All

Ages: 7 to 15 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• no clinical and radiographic evidence of pulp pathology,
• no clinical and radiographic symptoms,
• no history of spontaneous pain and tenderness,
• no percussion, swelling or sinus tracts and pathologic mobility.

Exclusion criteria

• any clinical or radiographic evidence of pulp degeneration (spontaneous or nocturnal tooth pain, tenderness to percussion, pathological mobility, internal or external root resorption, swelling or fistula, widened periodontal ligament (PDL)
• furcal or periapical radiolucency teeth requiring more than 5 minutes to achieve hemostasis during clinical procedure.
• without permanent successor

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

200 participants in 2 patient groups

Biodentine

Experimental group

Description:

Dental materials

Treatment:

Drug: Biodentine

Drug: ProRoot (Aggregate)

ProRoot MTA

Experimental group

Description:

Dental Materials

Treatment:

Drug: Biodentine

Drug: ProRoot (Aggregate)